Abiopharma

Treace Medical Secures Up to $175 Million in Debt Financing

Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026

Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management

Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives

Avantor, Inc. - Avantor® Appoints Simon Dingemans to its Board of Directors

Butterfly Network, Inc. - Butterfly Network to Present at the 44th Annual J.P. Morgan Healthcare Conference

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Avantor® Appoints Simon Dingemans to its Board of Directors

Johnson & Johnson - Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

Ovid Therapeutics Inc. - Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)